Ledger.Open graph →
SEC Form D · Amendment · filed February 26, 2018

Hapten Sciences, Inc

Offering
$2.0M
Sold
$633K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MEMPHIS, TN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Gary Prosterman · Memphis, TNExec · DirectorRaymond J. Hage · Memphis, TNExec · DirectorGary L. Stevenson · Memphis, TNDirectorStephen L. Bandak · Memphis, TNDirectorDavid Cordo · Cambridge, MADirectorMark Azzopardi · Triq il-Qatta Swieqi, O1DirectorDaniel Hicklin · Cambridge, MAExec · DirectorArnold Oronsky · Cambridge, MAExec · DirectorLuke Evnin · Cambridge, MADirectorSakae Asanuma · Cambridge, MAExec · DirectorWesley Capital Management, LLC · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗